ஜர்னல் ஆஃப் ஹெமாட்டாலஜி & த்ரோம்போம்போலிக் நோய்கள்
திறந்த அணுகல்

சுருக்கம்

Myelodysplastic Syndrome

Garima Yadav

Myelodysplastic conditions (MDS) normally assigned as bone marrow (BM) disappointment are a heterogeneous gathering of myeloid clonal issues brought about by a disappointment of platelets development. The co-morbidities result from a variable level of cytopenia and clonal flimsiness with an inclination to movement chiefly into intense myeloid leukemia (AML) however uncommon into intense lymphoblastic leukemia [1]. MDS is uncommon under 40 years of age, as indicated by Surveillance, Epidemiology and End Reports (SEER), the assessed frequency increments with age with fivefold distinction in hazard between age 60 and